Precision BioSciences (DTIL) Tops Q2 EPS by 15c

Precision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($0.10), $0.15 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $19.79 million versus the consensus estimate of $6.19 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• Lennar Corp. (LEN) Misses Q2 EPS by 1c